Ekso Bionics Holdings, Inc. Approves Appointment of Jerome Wong as Chief Financial Officer
October 31, 2022 at 06:09 am EDT
Share
On October 26, 2022, Ekso Bionics Holdings, Inc.'s (the Company") board of directors (the Board") approved the appointment of Jerome Wong as Chief Financial Officer, effective immediately. Mr. Wong has served as the Company's interim Chief Financial Officer and interim Principal Financial Officer since June 2022.
Ekso Bionics Holdings, Inc. designs, develops, and markets exoskeleton products. Its exoskeleton technology serves multiple markets and can be utilized both by able-bodied persons and persons with physical disabilities or impairments. Its products include EksoNR, which is a wearable robotic exoskeleton specifically designed to be used in a rehabilitation setting; Ekso Indego Therapy is a modular, adjustable, lightweight, lower-limb powered exoskeleton; Ekso Indego Personal is a lightweight powered lower limb orthosis; Ekso Nomad is a power Knee Ankle Foot Orthosis, and Ekso EVO is a wearable upper body exoskeleton. The Company enables individuals with neurological conditions affecting gait, including acquired brain injury (ABI) and spinal cord injury (SCI), to rehabilitate and to walk again; assist individuals with a range of upper extremity impairments and allow industrial workers to perform difficult repetitive work for extended periods. Its segments include EksoHealth and EksoWorks.
EKSO BIONICS HOLDINGS, INC. 
